Shelton Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-67,416
Closed -$6.69M 892
2019
Q3
$6.69M Sell
67,416
-7,429
-10% -$706K 0.4% 58
2019
Q2
$6.92M Buy
74,845
+67,741
+954% +$6.43M 0.4% 58
2019
Q1
$75.3K Sell
7,104
-68,217
-91% -$5.97M 0.3% 70
2018
Q4
$4.83M Sell
75,321
-5,357
-7% -$395K 0.33% 68
2018
Q3
$7.22M Sell
80,678
-18,237
-18% -$1.61M 0.41% 53
2018
Q2
$7.86M Buy
98,915
+137
+0.1% +$11.4K 0.49% 42
2018
Q1
$8.81M Buy
98,778
+6,860
+7% +$659K 0.58% 35
2017
Q4
$9.59M Sell
91,918
-540
-0.6% -$60.9K 0.62% 33
2017
Q3
$13.5M Sell
92,458
-9,615
-9% -$1.31M 0.91% 17
2017
Q2
$13.3M Buy
102,073
+6,766
+7% +$829K 0.94% 18
2017
Q1
$11.9M Buy
95,307
+5,313
+6% +$636K 0.82% 18
2016
Q4
$10.4M Sell
89,994
-375
-0.4% -$41.8K 0.79% 19
2016
Q3
$9.45M Buy
90,369
+1
+0% +$108 0.79% 21
2016
Q2
$8.91M Buy
90,368
+2,200
+2% +$228K 0.79% 21
2016
Q1
$8.82M Buy
88,168
+2,721
+3% +$280K 0.8% 20
2015
Q4
$10.2M Buy
85,447
+540
+0.6% +$62.5K 0.99% 17
2015
Q3
$9.18M Buy
84,907
+3,334
+4% +$414K 1.01% 14
2015
Q2
$9.44M Buy
81,573
+3,099
+4% +$354K 0.98% 17
2015
Q1
$9.05M Buy
78,474
+6,276
+9% +$750K 0.98% 15
2014
Q4
$8.08M Buy
72,198
+7,022
+11% +$741K 0.94% 15
2014
Q3
$6.18M Buy
65,176
+3,556
+6% +$321K 0.83% 17
2014
Q2
$5.29M Buy
61,620
+1,036
+2% +$78.8K 0.74% 19
2014
Q1
$4.23M Buy
60,584
+2,420
+4% +$192K 0.62% 26
2013
Q4
$4.91M Sell
58,164
-20,092
-26% -$1.59M 0.74% 19
2013
Q3
$6.02M Sell
78,256
-42
-0.1% -$2.94K 1.01% 11
2013
Q2
$4.58M Buy
+78,298
New +$4.71M 0.84% 19

Other funds holding CELG

Shelton Capital Management's CELG Position: Q4 2019 in Review

Shelton Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 67,416 shares — an estimated $6.69M sold.

Shelton Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $13.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Shelton Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Shelton Capital Management sold 67,416 Celgene Corp shares in Q4 2019, an estimated $6.69M.
  • Shelton Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Shelton Capital Management's Celgene Corp position peaked at $13.5M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Shelton Capital Management's 13F filing for Q4 2019, filed 11 Feb 2020.